Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Lilia-Celine Lozada's Stock Ratings
JP Morgan Analyst
Lilia-Celine Lozada is an analyst at JP Morgan. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/20/2025
Overall Average Return
-8.63%
Smart Score
Overall Average Return Percentile
22nd
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/27/2025 | ATRC | Buy Now | AtriCure | $31.40 | 46.5% | Lilia-Celine Lozada27% | $51 → $46 | Maintains | Overweight | Get Alert |
| 02/11/2025 | ATRC | Buy Now | AtriCure | $31.40 | 62.42% | Lilia-Celine Lozada27% | $40 → $51 | Maintains | Overweight | Get Alert |
| 12/17/2024 | TMCI | Buy Now | Treace Medical Concepts | $5.46 | 46.52% | Lilia-Celine Lozada27% | → $8 | Assumes | → Neutral | Get Alert |
| 12/17/2024 | ATRC | Buy Now | AtriCure | $31.40 | 27.39% | Lilia-Celine Lozada27% | → $40 | Assumes | → Overweight | Get Alert |
